Drug Profile
Aceclofenac/eperisone
Alternative Names: Eperisone/aceclofenac; HCP-1104Latest Information Update: 17 Feb 2016
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Analgesics; Esters; Muscle relaxants; Neuroprotectants; Nonsteroidal anti-inflammatories; Phenylacetates; Piperidines; Propiophenones; Small molecules
- Mechanism of Action Calcium channel antagonists; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Back pain
Most Recent Events
- 17 Feb 2016 Discontinued - Phase-II for Back pain in South Korea (PO)
- 01 Jul 2013 Hanmi Pharmaceutical completes its phase II trial in Back pain in South Korea (NCT01806818)
- 03 Jun 2013 Hanmi Pharmaceutical plans a phase I trial in healthy volunteers in South Korea (NCT01869985)